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Abstract  
As the number of patients infected by COVID-19 increases worldwide, and in the absence of appropriate 
therapeutic drugs or vaccines, it is essential to detect patients with COVID-19 pneumonia at its early stages, in 
order to isolate the patients from healthy population. Computed tomography (CT) scan seems to be promising 
in detection of COVID-19 as shown in some studies. 
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INTRODUCTION 
As the number of patients infected by COVID-19 
increases worldwide, and in the absence of 
appropriate therapeutic drugs or vaccines, it is 
essential to detect patients with COVID-19 
pneumonia at its early stages, in order to isolate the 
patients from healthy population. Computed 
tomography (CT) scan seems to be promising in 
detection of COVID-19 as shown in some studies. Ai 
et al. evaluated 1014 patients in Wuhan, China, for 
whom chest CT scan and reverse transcriptase-
polymerase chain reaction (RT-PCR) was 
performed. The sensitivity of chest CT in detection 
of COVID-19 was 97% in patients with positive RT-
PCR results. Sixty to 93% of patients had positive 
chest CT findings for COVID-19 before or at the 
same time as the initial positive RT-PCR results. On 
the other hand, typical CT scan findings were found 
in more than 70% of patients with negative RT-PCR 
tests, which could be due to overlap of CT imaging 
features of COVID-19 and other viral pneumonias or 
the high false-negative rate of the RT-PCR tests (1). In 
a recently performed meta-analysis, the pooled 
sensitivity and specificity of chest CT for detection 
of COVID-19 were 94% and 37%, respectively, 
whereas the pooled sensitivity of RT-PCR was 89% 
(2). 
SHOULD A CHEST CT SCAN BE USED FOR DIAGNOSIS OF 
COVID-19? 
Some patients had a negative chest CT scan during 
the first two days after the initial symptom, with 
ground-glass opacity (GGO) appearing between 
days 0 and 4 after symptom onset and peaking at 6-
13 days (3-7). Therefore, a negative chest CT does not 
rule out the possibility of COVID-19 infection, 
particularly in the early phase. Chest CT scan 
findings may become apparent prior to the positive 
RT-PCR test. An initially negative RT-PCR may take 
up to 4 days to convert in a patient with COVID-19 
(1). CT scan has been reported to be more sensitive 
than RT-PCR earlier in the course of the disease (8). 
In a population with a high pretest probability for 
the disease, the positive and negative predictive 
values of chest CT for COVID-19 were estimated as 
92% and 42%, respectively (9).  
This relatively low negative predictive value 
suggests that at least in earlier stages of the disease, 
CT may not be valuable as a screening test for 
COVID-19. Considering the fact that chest CT scan 
findings are not specific for COVID-19 and overlap 
with other infections, the American College of 
Radiology (ACR) recommends that CT should not be 
used for screening or as a first-line test to diagnose 
COVID-19 and should be used for hospitalized, 
symptomatic patients with specific clinical 
indications. Viral testing is considered as the only 
specific method of diagnosis. A normal chest CT 
does not rule out COVID-19 infection and an 
abnormal CT is not specific for COVID-19 diagnosis 
(10).  
In another statement, the Royal College of Radiology 
(RCR) announced that “as the current evidence does 
not demonstrate a clear benefit in producing a 
definitive and positive management change on the 
basis of CT information, there is no current role for 
CT in the diagnostic assessment of patients with 
suspected coronavirus infection in the UK. The CT 
request should be based on clinical need and 
management plan. The CT appearances alone will 
not obviate the need for viral testing and should not 
be viewed as equivalent to or replacing this” (11).  
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CHEST CT SCAN FINDINGS OF COVID-19 PNEUMONIA 
Several recently published papers have described 
CT imaging features of COVID-19, and the evolution 
of these features over time (3, 4, 12-14). The most 
common imaging features were peripheral GGO 
with or without consolidation, especially in the 
posterior or lower lung zone (3, 4, 12-15). GGO has also 
been frequently reported to have round 
morphology or be associated with interlobular 
septal thickening (“crazy paving”), which are often 
bilateral and multilobar (3, 12).  However, a significant 
portion of cases have opacities with nonspecific 
distribution (3). Linear, curvilinear or perilobular 
opacities, and diffuse GGO are also reported. They 
can mimic several disease processes including other 
infections, inhalational injuries, and drug toxicities 
(16-19). In most cases, perihilar involvement was not 
reported (3).  
Mucoid impactions, Bronchial wall thickening, and 
nodules (“tree-in-bud” and centrilobular), which 
are common in some infections, are not typical 
findings of COVID-19 pneumonia (3). Pleural effusion 
and lymphadenopathy were rarely reported (12, 20). 
Radiological Society of North America Expert 
Consensus suggested using a standardized language 
for reporting chest CT scan findings in patients with 
suspected COVID-19 infection. They categorized 
commonly reported imaging features of COVID-19 
including peripheral bilateral GGO or multifocal 
GGO of rounded morphology with or without 
consolidation or visible “crazy paving”, Reverse halo 
sign, or other findings of organizing pneumonia as 
typical features.  
The indeterminate group included findings that 
have been reported in COVID-19 pneumonia but are 
not specific, including non-rounded, non-
peripheral, multifocal, diffuse, perihilar, or 
unilateral GGO with or without consolidation 
lacking a specific distribution or few very small 
GGOs with a non-rounded and non-peripheral 
distribution. Atypical features included isolated 
lobar or segmental consolidation without GGO, 
discrete small nodules (centrilobular, “tree in- 
bud”), lung cavitation, and smooth interlobular 
septal thickening with pleural effusion. They are 
reported to be uncommon or not occurring in 
COVID-19 pneumonia and are more typical of other 
diseases. The CT scan imaging features of COVID-19 
patients are reported in table 1, and illustrated in 
figures 1-3 (21). 
Table 1: The CT scan imaging features of COVID-19 patients 
The typical features 
Peripheral bilateral or multifocal GGO of rounded morphology with or without consolidation 
Visible “crazy paving” 
Reverse halo sign 
Other findings of organizing pneumonia  
The indeterminate features 
Non-rounded, non-peripheral, multifocal, diffuse, perihilar, or unilateral GGO with or without consolidation lacking a specific 
distribution  
Few very small GGOs with a non-rounded and non-peripheral distribution 
The atypical features  
Isolated lobar or segmental consolidation without GGO 
Discrete small nodules (centrilobular, “tree in- bud”) 
Lung cavitation 
Smooth interlobular septal thickening with pleural effusion 
 
  
Figure 1: Typical imaging findings of COVID-19 pneumonia. Bilateral peripheral ground glass opacities in a 52-year-old man with 
cough and dyspnea 
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IMAGING FEATURES INDICATIVE OF DISEASE SEVERITY 
Patients with COVID-19 pneumonia could have 
various degrees of lung involvement, ranging from 
mild with small patches of GGO to severe forms with 
diffuse bilateral consolidation. Li et al. concluded 
that the incidence of consolidation, linear opacities, 
and crazy-paving pattern in severe or critically ill 
patients was significantly higher than that observed 
in other patients. These severely/critically ill 
patients were older and had more co-morbidities 
(22).  
Yuan et al. scored CT attenuation of pulmonary 
opacities (1 for normal attenuation, 2 for ground 
glass and 3 for consolidation) and degree of lung 
involvement in upper, middle and lower zones on 
each side using a 5-point scale (0 no involvement, 1 
less than 25%, 2: 25–50%, 3: 50-75% and 4: >75%), 
and calculated CT score. The maximal CT score was 
72. The cut-off value of 24.5 for the CT score, 
predicted mortality with 85.6% sensitivity and 
84.5% specificity. The frequency of consolidations 
was also higher in the mortality group (23).  
TEMPORAL CHANGES OF IMAGING FINDINGS 
In a study performed by Pan et al., they 
retrospectively evaluated twenty-one patients who 
had recovered from COVID-19 pneumonia and 
defined 4 stages of lung involvement on CT. In the 
early stage (0-4 days after onset of the initial 
symptom), unilateral or bilateral subpleural GGO in 
the lower lobes was the main imaging finding. Four 
patients had negative chest CT; however, they 
showed lung abnormalities in follow up CT scans (4).  
In the progressive stage (5-8 days after the onset of 
the initial symptom), the opacities increased in 
number and size and led to bilateral multi-lobar 
diffuse GGO, crazy-paving pattern, and 
consolidation. In the Peak stage (9-13 days after the 
onset of the initial symptom), the involved areas 
were slowly reaching the peak involvement and 
dense consolidation became more prevalent. 
Typical findings at this stage were diffuse GGO, 
crazy-paving pattern, consolidation, and residual 
parenchymal bands (4).  
Lung abnormalities on chest imaging were most 
severe approximately 10 days after symptom onset. 
In the last stage, which was called the absorption 
stage (≥14 days after the onset of the initial 
symptom), consolidations had gradually diminished 
and no crazy-paving pattern was present anymore. 
However, in this stage, extensive GGO could be 
observed as the result of the consolidation 
absorption. Figure 4 shows one example in this 
regard (4).  
In another study, among patients who clinically 
improved, resolutions of radiographic 
abnormalities were reported to happen after 
improvements in fever and hypoxia (24). 
 
Figure 2: Typical imaging findings of COVID-19 
pneumonia. Peripheral ground glass opacity with 
interlobular septal thickening (crazy paving pattern) 
 
 
Figure 3: Atypical imaging features for COVID-19 
pneumonia.  Bilateral diffuse tree in bud opacities (the 
patient was a 60-year-old man with positive tuberculosis 
tests in diagnostic work up) 
 
Figure 4: Diffuse consolidation in the left lung and patchy 
peripheral consolidations in the peak phase of COVID-19 
pneumonia 
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CONCLUSION 
Although CT scan has high sensitivity in detecting 
COVID-19 pneumonia, according to the published 
statements, it should not be used as a diagnostic or 
screening method. The most common chest CT scan 
finding of COVID-19 pneumonia is peripheral GGO 
with or without consolidations, especially in 
posterior and lower regions of lungs. Crazy paving, 
reverse halo sign and other imaging findings of 
organizing pneumonia are also considered typical. 
As time passes, opacities increase in number and 
size to reach the most severe stage at about 10 days 
from initial symptoms. Opacities eventually start to 
diminish in the absorption phase. 
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